Clinicopathological features, treatment outcomes, and prognostic factors of angiosarcoma: a 21-year experience at one center
This study underscores the heterogeneity of angiosarcoma across different sites, emphasizing the role of surgery for localized AS, and chemotherapy remains the mainstay for advanced cases. Targeted therapies and immunotherapies offer novel promise, especially the combination strategies.
Authors
- Chenyan Fang
- Xiaoting Zeng
- Meiyu Fang (ORCID: https://orcid.org/0000-0001-9369-3640)
- Qing Ji (ORCID: https://orcid.org/0000-0002-1899-0204)
- Jun Cao (ORCID: https://orcid.org/0000-0002-5591-2299)
- Tao Zhu (ORCID: https://orcid.org/0000-0002-2921-4067)
Institutions
- Zhejiang Chinese Medical University (CN)
- Zhejiang Cancer Hospital (CN)
- Hangzhou Cancer Hospital (CN)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Orphanet Journal of Rare Diseases
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1186/s13023-025-03819-9
- Citations
- 3
- Primary Topic
- Vascular Tumors and Angiosarcomas
- Type
- article
- Field-Weighted Citation Impact
- 3.14
Funders
- Medical and Health Research Project of Zhejiang Province